HVCN1 and Parkinson disease: Similar to the human expression data, a significant increase in Hvcn1 mRNA level was observed in the striatum two days following the last injection of MPTP, which is consistent with findings that 24–48 h post-MPTP represents the peak inflammatory response in the striatum [81,82] and precedes dopamine neuron loss in this PD model [83].